With over a decade of experience in caring for women, her focus has been on family planning at FPA Womens Health in California, where she also led the Weigh to Wellness weight-loss program, managed their prenatal program, and spearheaded their telehealth platform, which has been running for over five years
Meta-analysis of these 8 CVOTs included more than 60 000 patients and aimed to evaluate the influence of GLP-1 receptor agonists on cardiovascular system
Misuse increases the risk of serious outcomes, including: Cardiovascular risks Vyvanse can increase heart rate and blood pressure
GLP-1 Therapy are FDA-approved weight loss medication therapies
End-to-end vertical integration
February 18, 2026: Ozempic Manufacturer Runs $20 Million Super Bowl Ad Despite Mounting Lawsuits Novo Nordisk, which makes the GLP-1 drugs Ozempic and Wegovy, aired a high-profile ad during Super Bowl LX that reportedly cost more than $20 million